Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Haemonetics Corporation (NYSE: HAE)
HAE Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
5.30%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-40.10%
HAE Stock Analysis
HAE
PE Ratio:
32.1
HAE
PEG Ratio:
3.1
HAE
Forward EPS Growth (12 month):
10.50%
HAE
PS Ratio:
2.2
HAE
PSG Ratio:
0.4
HAE
Forward Revenue Growth (12 month):
5.30%
HAE Articles
No data was found